跳至主要内容
临床试验/NCT03978481
NCT03978481已完成不适用

Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 3,700 人开始时间: 2019年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3,700
试验地点
1
主要终点
Overall survival

研究概览

简要总结

In this study, we will observe the long-term survival rate, overall mortality rate, gastric cancer specific mortality rate, and the incidence rate of metachronous cancer in patients who received subtotal gastrectomy, with or without Helicobacter pylori eradication.

详细描述

In this study, we will observe the long-term survival rate, overall mortality rate, gastric cancer specific mortality rate, and the incidence rate of metachronous cancer in patients who received subtotal gastrectomy, with or without Helicobacter pylori eradication. In addition, we will analyze the correlation between the incidence and survival rate of this type of stomach cancer by comparing smoking, gastric cancer direct family history, disease stage (TNM staging), the histologic type of stomach cancer (intestinal, diffuse, mixed), and the surgical method (Billoth I, Billoth II) as well as the infection and eradication status of H. pylori.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with gastric cancer and received surgery (partial, distal, subtotal gastrectomy), and tested Helicobacter pylori status

排除标准

  • Patients with other severe diseases (other primary cancer, severe cardiovascular, cerebral, renal, hepatic diseases)
  • Patients received palliative treatment

结局指标

主要结局

Overall survival

时间窗: From date of initial curative surgery for gastric cancer, until the date of death from any cause, up to 60 months

次要结局

  • Gastric cancer-specific (disease-free) survival(From date of initial curative surgery for gastric cancer, until the date of diagnosis of gastric cancer recurrence or the date of death, whichever comes first, up to 60 months)
  • Metachronous cancer (remnant stomach cancer)(Up to 60 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nayoung Kim

Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验